BENZENESULFONANILIDE COMPOUNDS SUITABLE FOR TREATING DISORDERS THAT RESPOND TO MODULATION OF THE SEROTONIN 5-HT6 RECEPTOR

The present invention relates to novel benzenesulfonanilide compounds of the formulae I and I′ and physiologically tolerated acid addition salts and the N-oxides thereof. The compounds possess valuable therapeutic properties and are particularly suitable, for treating diseases that respond to modula...

Full description

Saved in:
Bibliographic Details
Main Authors DRESCHER KARLA, WICKE KARSTEN, BRAJE WILFRIED MARTIN, JONGEN-RELO ANA LUCIA, BESPALOV ANTON, MAYRER MATTHIAS, WERNET WOLFGANG, UNGER LILIANE, ZHANG MIN, HAUPT ANDREAS, MEZLER MARIO, TURNER SEAN COLM, LANGE UDO
Format Patent
LanguageEnglish
Published 23.02.2011
Online AccessGet full text

Cover

Loading…
More Information
Summary:The present invention relates to novel benzenesulfonanilide compounds of the formulae I and I′ and physiologically tolerated acid addition salts and the N-oxides thereof. The compounds possess valuable therapeutic properties and are particularly suitable, for treating diseases that respond to modulation of the serotonin 5-HT6 receptor. wherein R1 is hydrogen or methyl R2 is hydrogen or methyl R3 hydrogen, fluorine C1-C2 alkoxy or fluorinated C1-C2 alkoxy; R4 is hydrogen, C1-C4 alkyl or fluorinated C1-C4 alkyl; R5 is hydrogen, fluorine, C1-C2 alkyl, fluorinated C1-C2 alkyl, C1-C2 alkoxy or fluorinated C1-C2 alkoxy; and R6 is hydrogen, fluorine and chlorine.
Bibliography:Application Number: ZA20100003594